Tex. Gov't Code § 549.0205 · Subchapter E. PREFERRED DRUG LISTS
CONSIDERATIONS FOR INCLUDING DRUG ON PREFERRED DRUG LISTS.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) In making a decision regarding the placement of a drug on each of the preferred drug lists adopted under this subchapter, the commission shall consider:
(1) the board's recommendations under Section 549.0309;
(2) the drug's clinical efficacy;
(3) the price of competing drugs after deducting any federal and state rebate amounts; and
(4) program benefit offerings solely or in conjunction with rebates and other pricing information.
(b) The commission shall consider including on a preferred drug list:
(1) multiple methods of delivery within each drug class, including liquid, capsule, and tablet, including an orally disintegrating tablet; and
(2) all strengths and dosage forms of a drug.
Notes and commentary — not statutory text
History
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/GV/htm/GV.549.htm
- Text hash
- sha256 2a3b2ac9cf99b320b2f3bc8bcefa847a5879972d246850e44f48623ea4ff28c2
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
This section cites
Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.